Heidi Taipale

9.1k total citations · 5 hit papers
257 papers, 5.8k citations indexed

About

Heidi Taipale is a scholar working on Psychiatry and Mental health, Geriatrics and Gerontology and Clinical Psychology. According to data from OpenAlex, Heidi Taipale has authored 257 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 177 papers in Psychiatry and Mental health, 54 papers in Geriatrics and Gerontology and 40 papers in Clinical Psychology. Recurrent topics in Heidi Taipale's work include Schizophrenia research and treatment (112 papers), Bipolar Disorder and Treatment (66 papers) and Dementia and Cognitive Impairment Research (50 papers). Heidi Taipale is often cited by papers focused on Schizophrenia research and treatment (112 papers), Bipolar Disorder and Treatment (66 papers) and Dementia and Cognitive Impairment Research (50 papers). Heidi Taipale collaborates with scholars based in Finland, Sweden and United States. Heidi Taipale's co-authors include Jari Tiihonen, Antti Tanskanen, Sirpa Hartikainen, Anna‐Maija Tolppanen, Marjaana Koponen, Christoph U. Correll, Juha Mehtälä, Markku Lähteenvuo, Ellenor Mittendorfer‐Rutz and Pia Vattulainen and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and American Journal of Psychiatry.

In The Last Decade

Heidi Taipale

237 papers receiving 5.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia

2017 438 citations Jari Tiihonen, Ellenor Mittendorfer‐Rutz et al. profile →
Mortality in people with schizophrenia: a systematic review and meta‐analysis of relative risk and aggravating or attenuating factors

2022 334 citations Christoph U. Correll, Marco Solmi et al. profile →
20‐year follow‐up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20)

2020 260 citations Heidi Taipale, Antti Tanskanen et al. profile →
Half a century of research on antipsychotics and schizophrenia: A scientometric study of hotspots, nodes, bursts, and trends

2022 129 citations Heidi Taipale, Antti Tanskanen et al. profile →
Repurposing Semaglutide and Liraglutide for Alcohol Use Disorder

2024 42 citations Markku Lähteenvuo, Jari Tiihonen et al. profile →

Peers

Countries citing papers authored by Heidi Taipale

Since Specialization

Citations

This map shows the geographic impact of Heidi Taipale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heidi Taipale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heidi Taipale more than expected).

Fields of papers citing papers by Heidi Taipale

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heidi Taipale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heidi Taipale. The network helps show where Heidi Taipale may publish in the future.

Co-authorship network of co-authors of Heidi Taipale

This figure shows the co-authorship network connecting the top 25 collaborators of Heidi Taipale. A scholar is included among the top collaborators of Heidi Taipale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heidi Taipale. Heidi Taipale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Factors associated with long-term hypnotics use in depression 2026 ·Journal of Affective Disorders ·(unknown), Pär Karlsson, Mikael Tiger, Philip Brenner, (unknown), (unknown), (unknown), (unknown), Heidi Taipale, (unknown)	0
2	Socio‐economic differences in the effectiveness of pharmacotherapy use in alcohol use disorder: A cohort study of 148 626 individuals in Sweden 2025 ·Addiction ·(unknown), (unknown), (unknown), Jari Tiihonen, Anders Hammarberg, Daniel Falkstedt, Heidi Taipale	0
3	Characteristics of high-dose benzodiazepine use: nationwide cohort study on new benzodiazepine users with 5-year follow-up 2024 ·BJPsych Open ·(unknown), Heidi Taipale, Antti Tanskanen, Terhi Kurko, Tero Taiminen, Jari Tiihonen, Reijo Sund, Leena Saastamoinen, Jarmo Hietala, Solja Niemelä	1
4	Antipsychotic Use and Risk of Breast Cancer in Women With Severe Mental Illness: Replication of a Nationwide Nested Case–Control Database Study 2024 ·Schizophrenia Bulletin ·Marco Solmi, Markku Lähteenvuo, Antti Tanskanen, (unknown), Ellenor Mittendorfer‐Rutz, Christoph U. Correll, Jari Tiihonen, Heidi Taipale	8
5	The role of sociodemographic and clinical factors in the initiation and discontinuation of attention deficit hyperactivity disorder medication among young adults in Sweden 2023 ·Frontiers in Psychiatry ·Katalin Gémes, Heidi Taipale, Emma Björkenstam, Syed Rahman, Klas Gustafsson, Antti Tanskanen, Lisa Ekselius, Ellenor Mittendorfer‐Rutz, Magnus Helgesson	2
6	Use of antipsychotics and antidepressants in first‐episode psychotic depression: A nationwide register‐based study 2023 ·Acta Psychiatrica Scandinavica ·Aleksi Hamina, Tapio Paljärvi, Antti Tanskanen, Markku Lähteenvuo, Jari Tiihonen, Heidi Taipale	1
7	Real-world effectiveness of pharmacological treatments for bipolar disorder: register-based national cohort study 2023 ·The British Journal of Psychiatry ·Markku Lähteenvuo, Tapio Paljärvi, Antti Tanskanen, Heidi Taipale, Jari Tiihonen	18
8	Patient factors associated with receipt of psychological and pharmacological treatments among individuals with common mental disorders in a Swedish primary care setting 2023 ·BJPsych Open ·Alexis E. Cullen, Elin Lindsäter, Syed Rahman, Heidi Taipale, Antti Tanskanen, Ellenor Mittendorfer‐Rutz, Magnus Helgesson	5
9	Comparison of Hospitalization for Nonaffective Psychotic Disorders Among Refugee, Migrant, and Native-Born Adults in Sweden and Denmark 2023 ·JAMA Network Open ·Alexis E. Cullen, (unknown), Marie Nørredam, Jakob Bergström, Allan Krasnik, Heidi Taipale, Ellenor Mittendorfer‐Rutz	3
10	Real-world effectiveness of antidepressant use in persons with schizophrenia: within-individual study of 61,889 subjects 2023 ·Schizophrenia ·(unknown), Marjaana Koponen, Markku Lähteenvuo, Antti Tanskanen, Jari Tiihonen, Heidi Taipale	8
11	Real‐world effectiveness of mood stabilizer use in schizophrenia 2022 ·Acta Psychiatrica Scandinavica ·(unknown), Marjaana Koponen, Markku Lähteenvuo, Antti O. Tanskanen, Jari Tiihonen, Heidi Taipale	11
12	Employment among people with schizophrenia or bipolar disorder: A population-based study using nationwide registers 2021 ·STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) ·Minna Torniainen‐Holm, Heidi Taipale, Antti Tanskanen, Jari Tiihonen, (unknown)	2
13	Antipsychotic use and risk of breast cancer in women with schizophrenia: a nationwide nested case-control study in Finland 2021 ·The Lancet Psychiatry ·Heidi Taipale, Marco Solmi, Markku Lähteenvuo, Antti Tanskanen, Christoph U. Correll, Jari Tiihonen	83
14	Morbidity and mortality in schizophrenia with comorbid substance use disorders 2021 ·Acta Psychiatrica Scandinavica ·Markku Lähteenvuo, Albert Batalla, Jurjen J. Luykx, Ellenor Mittendorfer‐Rutz, Antti Tanskanen, Jari Tiihonen, Heidi Taipale	40
15	Antipsychotics Use Is Associated With Greater Adherence to Cardiometabolic Medications in Patients With Schizophrenia: Results From a Nationwide, Within-subject Design Study 2021 ·Schizophrenia Bulletin ·Marco Solmi, Jari Tiihonen, Markku Lähteenvuo, Antti Tanskanen, Christoph U. Correll, Heidi Taipale	45
16	Association of recent hospitalisation with antidepressant initiation among community dwellers with Alzheimer's disease 2021 ·International Journal of Geriatric Psychiatry ·(unknown), Sirpa Hartikainen, Heidi Taipale, Antti Tanskanen, Marjaana Koponen, Anna‐Maija Tolppanen	5
17	The risk of Alzheimer's disease associated with benzodiazepines and related drugs: a nested case–control study 2018 ·Acta Psychiatrica Scandinavica ·(unknown), Heidi Taipale, Antti Tanskanen, Jari Tiihonen, Sirpa Hartikainen, Anna‐Maija Tolppanen	4
18	Duration of new antidepressant use and factors associated with discontinuation among community-dwelling persons with Alzheimer’s disease 2018 ·European Journal of Clinical Pharmacology ·(unknown), Heidi Taipale, Anna‐Maija Tolppanen, Antti Tanskanen, Jari Tiihonen, Sirpa Hartikainen, Marjaana Koponen	8
19	Antipsychotic Use And The Risk Of Hip Fracture Among Community-Dwelling Persons With Alzheimer's Disease 2017 ·STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) ·Marjaana Koponen, Heidi Taipale, Piia Lavikainen, Antti Tanskanen, Jari Tiihonen, Anna‐Maija Tolppanen, Riitta Ahonen, Sirpa Hartikainen	0
20	Risk of head and traumatic brain injuries associated with antidepressant use among community-dwelling persons with Alzheimer’s disease: a nationwide matched cohort study 2017 ·Alzheimer s Research & Therapy ·Heidi Taipale, Marjaana Koponen, Antti Tanskanen, Piia Lavikainen, Reijo Sund, Jari Tiihonen, Sirpa Hartikainen, Anna‐Maija Tolppanen	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact